Obsessive-compulsive disorder: A double-blind, placebo-controlled trial of clomipramine in 27 patients

68Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Clomipramine was significantly superior to placebo in a 10-week double-blind, placebo-controlled trial in 27 outpatients who met DMS-III-R criteria for obsessive-compulsive disorder.

Cite

CITATION STYLE

APA

Jenike, J. A., Baer, L., Summergrad, P., Weilburg, J. B., Holland, A., & Seymour, R. (1989). Obsessive-compulsive disorder: A double-blind, placebo-controlled trial of clomipramine in 27 patients. American Journal of Psychiatry, 146(10), 1328–1330. https://doi.org/10.1176/ajp.146.10.1328

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free